Jasveen Sangha, notoriously dubbed the “Ketamine Queen,” has officially pleaded guilty to federal charges for supplying the ketamine that played a fatal role in actor Matthew Perry’s death in October 2023.
Why is Jasveen Sangha Linked to Matthew Perry’s Death?
In a federal courtroom in Los Angeles on September 3, 2025, Sangha admitted guilt to five felony counts, including maintaining a premises for drug activity, three counts of ketamine distribution, and one count of distribution resulting in death or serious bodily injury.
At 42 years old, Sangha became the final defendant in the case to reach a plea agreement with prosecutors, concluding a year-long criminal investigation that has seen all five suspects—including two doctors, Matthew Perry’s assistant, and a middleman—accept responsibility. Perry’s mother and stepfather were present in court as Sangha entered her plea.
Prosecutors say Sangha operated an illicit drug network from her North Hollywood residence, storing vast supplies of ketamine and other controlled substances. She is accused of supplying Perry—via an intermediary named Erik Fleming—with approximately 50 vials of ketamine, some of which were administered by his assistant Kenneth Iwamasa, contributing directly to Perry’s overdose and subsequent drowning.
In addition to this case, Sangha admitted involvement in a similar overdose death tied to ketamine in 2019. Following Perry’s death, she allegedly instructed Fleming to delete their communications in an apparent effort to eliminate incriminating evidence.
Sangha faces up to 65 years in federal prison, although as part of her plea agreement, prosecution may recommend a lighter sentence. Her formal sentencing is scheduled for December 10, 2025.
Sangha was the last of five individuals charged in connection with Perry’s death to accept a plea deal. The other co-defendants—including two doctors, Perry’s assistant, and an intermediary—have also pleaded guilty
This high-profile case has shone a light on the darker side of Hollywood drug culture and raised urgent discussions about accountability in cases involving controlled substances and high-profile figures. Sangha, a dual U.S. and U.K. citizen, has transformed from a privileged individual with a lavish lifestyle into a symbol of the legal consequences of unchecked drug distribution to celebrities.
With her guilty plea, Jasveen Sangha joins the sequence of other defendants in declaring responsibility, guiding this arguably tragic case toward closure—though the repercussions for all involved remain significant.
